An Evaluation Of The Effects Of Saffron Supplementation On The Asthma Clinical Symptoms And Asthma Severity In Patients With Mild And Moderate Persistent Allergic Asthma: A Double-blind, Randomized Placebo-controlled Trial
|Trial Design||Randomized trial|
|Trial Length||1-6 months|
|Number of Subjects||80|
In a randomized, double-blind, placebo-controlled trial, 80 participants with asthma took 100 mg of saffron or placebo daily or 8 weeks.
The primary outcome was asthma severity and the saffron group saw a greater improvement in parameters and required less salbutamol spray. The saffron group saw a greater improvement in LDL and triglycerides, whereas there wasn't an improvement in HDL.